A case of psoriatic arthritis, with joint involvement preceding skin involvement, successfully treated with adalimumab (80 mg every other week)

Here we present a 45-year-old male patient who suffered from psoriatic arthritis (PsA), for which adalimumab (80 mg every other week) was effective. Dose escalation of a TNF-α antagonist should be considered for patients showing an inadequate response for disease stabilization in PsA.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Immunological medicine 2019-06, Vol.42 (2), p.99-102
Hauptverfasser:	Nanke, Yuki, Kobashigawa, Tsuyoshi, Sugimoto, Naoki, Yamanaka, Hisashi, Kotake, Shigeru
Format:	Artikel
Sprache:	eng
Schlagworte:	adalimumab Adalimumab - administration & dosage Adalimumab - pharmacology Anti-Inflammatory Agents - administration & dosage Anti-Inflammatory Agents - pharmacology Arthritis, Psoriatic - complications Arthritis, Psoriatic - drug therapy Arthritis, Psoriatic - pathology biologic Drug Administration Schedule Humans Male Middle Aged psoriasis Psoriasis - drug therapy Psoriasis - etiology Psoriasis - pathology Psoriatic arthritis Severity of Illness Index Skin - pathology Treatment Outcome Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Here we present a 45-year-old male patient who suffered from psoriatic arthritis (PsA), for which adalimumab (80 mg every other week) was effective. Dose escalation of a TNF-α antagonist should be considered for patients showing an inadequate response for disease stabilization in PsA.
ISSN:	2578-5826 2578-5826
DOI:	10.1080/25785826.2019.1657255